Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Thomas Z. Benton"'
Autor:
Katie A. Meyer, Thomas Z. Benton, Brian J. Bennett, David R. Jacobs, Donald M. Lloyd‐Jones, Myron D. Gross, J. Jeffrey Carr, Penny Gordon‐Larsen, Steven H. Zeisel
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 10 (2016)
BackgroundClinical studies implicate trimethylamine N‐oxide (TMAO; a gut microbiota‐dependent nutrient metabolite) in cardiovascular disease risk. There is a lack of population‐based data on the role of TMAO in advancing early atherosclerotic d
Externí odkaz:
https://doaj.org/article/4b531065863b4ccfa0920b83f2aa6550
Autor:
Catherine M. Mills, Thomas Z. Benton, Ivett Piña, Megan J. Francis, Leticia Reyes, Nathan G. Dolloff, Yuri K. Peterson, Patrick M. Woster
Publikováno v:
Chemical Science. 14:2168-2182
Small molecule inhibitors of CD38 promote increases in interferon gamma and stimulate natural killer cell proliferation for the treatment of neuroblastoma.
Autor:
Megan J. Francis, Jonathan M. Turner, Pieter B. Burger, André S. Bachmann, Catherine M. Mills, Nathan G. Dolloff, Dalan J. Solomon, Patrick M. Woster, Yuri K. Peterson, Thomas Z. Benton
Publikováno v:
RSC Advances. 11:33260-33270
The ectoenzyme CD38 is highly expressed on the surface of mature immune cells, where they are a marker for cell activation, and also on the surface of multiple tumor cells such as multiple myeloma (MM). CD38-targeted monoclonal antibodies (MABs) such
Publikováno v:
Bioelectrochemistry. 129:235-241
During tribocorrosion of biomedical alloys, potentials may shift cathodically across the metal-oxide-electrolyte interface resulting in the increased reduction of local oxygen and water molecules. The products of reduction are thought to include reac
Autor:
J. Jeffrey Carr, Donald M. Lloyd-Jones, Penny Gordon-Larsen, Brian J. Bennett, David R. Jacobs, Myron D. Gross, Katie A. Meyer, Steven H. Zeisel, Thomas Z. Benton
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Clinical studies implicate trimethylamine N‐oxide ( TMAO ; a gut microbiota‐dependent nutrient metabolite) in cardiovascular disease risk. There is a lack of population‐based data on the role of TMAO in advancing early atheroscleroti
Autor:
Katie A Meyer, Thomas Z Benton, Brian Bennett, David R Jacobs, Donald M Lloyd-Jones, Myron D Gross, Penny Gordon-Larsen, Steven H Zeisel
Publikováno v:
Circulation. 133
Objective: Trimethylamine N-oxide (TMAO), a gut microbiota-dependent nutrient metabolite, has been implicated in the development of cardiovascular disease (CVD). TMAO is excreted in the urine and high levels may reflect poor kidney function, an indep